Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.25603
Abstract: Background and objectives: Hypertherm intraperitoneal chemotherapy (HIPEC) is increasingly used in the treatment of ovarian, tubal, and primary peritoneal cancer (OC). The aim was to evaluate shortâterm morbidity of cytoreductive surgery (CRS) and carboplatin HIPEC.
read more here.
Keywords:
peritoneal cancer;
intraperitoneal chemotherapy;
primary peritoneal;
morbidity cytoreductive ... See more keywords